Elypta raises funds to develop multi-cancer early detection test
The company has two studies in progress, LEVANTIS-0087A for MCED and AURORAX-0087A for kidney cancer recurrence.
Deals
Latest in
Deals
Boston Scientific to purchase stake in M.I.Tech for $230m
M.I.Tech has developed a family of conformable, self-expanding metal stents called HANAROSTENT.
OrthoPediatrics signs agreement to acquire Pega Medical
The Fassier-Duval Telescopic Intramedullary System corrects deformity of long bones while preventing or stabilising fractures.
Medical device maker ResMed agrees to buy MEDIFOX DAN for $1bn
The transaction is expected to expand ResMed’s SaaS business footprint outside the US.
BD signs agreement to buy Parata Systems for $1.5bn
Through the acquisition, BD will have access to a new pharmacy automation market segment worth $600m.
Debt offerings increased in the medical industry in H2 2021
Debt offerings in the medical sector have seen an increase of 20% from H2 2020 to H2 2021, an analysis…
By
Partnerships decreased significantly in the medical industry in H2 2021
Partnerships in the medical sector have seen a decrease of 50% from H2 2020 to H2 2021, an analysis of…
By
StageZero and DiagnoseAtHome to offer blood test in US and Canada
The test identifies gene expression profiles that indicate specific cancers by interrogating mRNA from a whole blood sample.